Plasma proteomic signatures of incident cardiovascular disease according to serum urate levels: a prospective cohort study

Hyperuricemia is associated with increased cardiovascular disease (CVD) risk. Whether plasma protein–CVD associations vary with serum urate and whether proteomic information adds predictive value in hyperuricemia remain unclear. This prospective UK Biobank study included 45823 participants without baseline CVD and Olink measurements of 2920 plasma proteins. Hyperuricemia ( n = 7336) was defined as serum urate >400 μmol/L in men or >360 μmol/L in women. CVD comprised coronary heart disease, stroke and heart failure. Multivariable Cox models tested protein interactions with continuous serum urate and, in complementary analyses, binary hyperuricemia status, with false discovery rate (FDR) correction. Among participants with hyperuricemia, weighted gene co-expression network analysis identified protein modules for functional enrichment analysis. In an exploratory prediction analysis, a proteomic risk score (ProRS) was developed using penalized Cox regression in the training set ( n = 5868) and evaluated in the internal validation set ( n = 1468). During a median follow-up of 13.4 years, 5636 participants developed CVD. At FDR < 0.05, 130 proteins showed interactions with continuous serum urate and five with hyperuricemia status; four (FAM3B, CELSR2, FAM3C, and CST6) were significant in both analyses with concordant directions. Module M02 contained 76 of the 130 continuous-urate interaction proteins and remained enriched after adjustment for Olink assay panel. M02 had vascular, extracellular matrix, and immune-related functional annotations. Each 1-SD higher M02 eigengene was associated with higher CVD risk (hazard ratio, 1.31; 95% CI, 1.22–1.41). Adding the 47-protein ProRS to the enhanced clinical model increased the validation C-index from 0.703 to 0.738 (difference, 0.0358; 95% CI, 0.0111–0.0591). The corresponding gain over this clinical model plus N-terminal pro-B-type natriuretic peptide (NT-proBNP) and growth differentiation factor 15 (GDF15) was 0.0133 (95% CI, −0.0001–0.0261). Plasma protein–CVD associations varied according to serum urate levels, with interaction proteins enriched in a module with vascular, extracellular matrix, and immune-related annotations. The 47-protein ProRS improved discrimination beyond the enhanced clinical model in the internal validation set. Independent replication and external validation are needed to assess reproducibility and clinical value.

Authors

Institutions

Publication Details

Journal
BMC Cardiovascular Disorders
Published
2026-11-12
DOI
https://doi.org/10.1186/s12872-026-06949-5
Primary Topic
Gout, Hyperuricemia, Uric Acid
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Plasma proteomic signatures of incident cardiovascular disease according to serum urate levels: a prospective cohort study

Yunfei Liao, J. Wang, Hancheng Yu, Yumei Huang et al.
BMC Cardiovascular Disorders
Gout, Hyperuricemia, Uric Acid
article

Plasma proteomic signatures of incident cardiovascular disease according to serum urate levels: a prospective cohort study

Yunfei Liao, J. Wang, Hancheng Yu, Yumei Huang, Gang Liu, An Pan
article en

Abstract

Hyperuricemia is associated with increased cardiovascular disease (CVD) risk. Whether plasma protein–CVD associations vary with serum urate and whether proteomic information adds predictive value in hyperuricemia remain unclear. This prospective UK Biobank study included 45823 participants without baseline CVD and Olink measurements of 2920 plasma proteins. Hyperuricemia ( n = 7336) was defined as serum urate >400 μmol/L in men or >360 μmol/L in women. CVD comprised coronary heart disease, stroke and heart failure. Multivariable Cox models tested protein interactions with continuous serum urate and, in complementary analyses, binary hyperuricemia status, with false discovery rate (FDR) correction. Among participants with hyperuricemia, weighted gene co-expression network analysis identified protein modules for functional enrichment analysis. In an exploratory prediction analysis, a proteomic risk score (ProRS) was developed using penalized Cox regression in the training set ( n = 5868) and evaluated in the internal validation set ( n = 1468). During a median follow-up of 13.4 years, 5636 participants developed CVD. At FDR < 0.05, 130 proteins showed interactions with continuous serum urate and five with hyperuricemia status; four (FAM3B, CELSR2, FAM3C, and CST6) were significant in both analyses with concordant directions. Module M02 contained 76 of the 130 continuous-urate interaction proteins and remained enriched after adjustment for Olink assay panel. M02 had vascular, extracellular matrix, and immune-related functional annotations. Each 1-SD higher M02 eigengene was associated with higher CVD risk (hazard ratio, 1.31; 95% CI, 1.22–1.41). Adding the 47-protein ProRS to the enhanced clinical model increased the validation C-index from 0.703 to 0.738 (difference, 0.0358; 95% CI, 0.0111–0.0591). The corresponding gain over this clinical model plus N-terminal pro-B-type natriuretic peptide (NT-proBNP) and growth differentiation factor 15 (GDF15) was 0.0133 (95% CI, −0.0001–0.0261). Plasma protein–CVD associations varied according to serum urate levels, with interaction proteins enriched in a module with vascular, extracellular matrix, and immune-related annotations. The 47-protein ProRS improved discrimination beyond the enhanced clinical model in the internal validation set. Independent replication and external validation are needed to assess reproducibility and clinical value.

BMC Cardiovascular Disorders
Wuhan Union Hospital (CN), Huazhong University of Science and Technology (CN)
National Natural Science Foundation of China
Good health and well-being
Gout, Hyperuricemia, Uric Acid
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon